James Gilligan
Presidente en TRYPTAMINE THERAPEUTICS LIMITED .
Relaciones activas
| Nombre | Sexo | Edad | Empresas relacionadas | Colaboración |
|---|---|---|---|---|
| Agnes Olszewski | M | 67 | 22 años | |
| James Kuo | M | 58 | 5 años | |
| Peter Molloy | M | 52 | 4 años | |
| Philip Jull | M | 64 | 4 años | |
| Sidney Taubenfeld | M | - | 2 años | |
| David S. Krause | M | - |
Tarsa Therapeutics, Inc.
 Tarsa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Tarsa Therapeutics, Inc. engages in the development of therapies for the treatment and prevention of osteoporosis and related bone diseases. Its product OSTORA, is an oral formulation of calcitonin, which is a recombinant peptide hormone that inhibits bone resorption. The company was founded by David Brand and James Gilligan in 2009 and is headquartered in Philadelphia, PA. | 14 años |
| Michael Silverman | M | - | - | |
| Christopher Ntoumenopoulos | M | - | 2 años | |
| Peter Guzzo | M | - | 4 años | |
| James O’Neill | M | 64 | 2 años | |
| Jason Carroll | M | - | 1 años |
Gráfico relacional
Relaciones con varias empresas
Antiguas relaciones
| Nombre | Sexo | Edad | Empresas relacionadas | Colaboración |
|---|---|---|---|---|
| Garner William | M | 58 | 3 años | |
| Gregory M. McKee | M | 60 | 1 años | |
| Dave Tousley | M | 69 | 1 años | |
| Don Soland | M | 65 |
Tarsa Therapeutics, Inc.
Tarsa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Tarsa Therapeutics, Inc. engages in the development of therapies for the treatment and prevention of osteoporosis and related bone diseases. Its product OSTORA, is an oral formulation of calcitonin, which is a recombinant peptide hormone that inhibits bone resorption. The company was founded by David Brand and James Gilligan in 2009 and is headquartered in Philadelphia, PA. | - |
| George R. Maurer | M | 68 |
Tarsa Therapeutics, Inc.
Tarsa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Tarsa Therapeutics, Inc. engages in the development of therapies for the treatment and prevention of osteoporosis and related bone diseases. Its product OSTORA, is an oral formulation of calcitonin, which is a recombinant peptide hormone that inhibits bone resorption. The company was founded by David Brand and James Gilligan in 2009 and is headquartered in Philadelphia, PA. | 5 años |
| Nicholas LaBella | M | 68 |
Tarsa Therapeutics, Inc.
Tarsa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Tarsa Therapeutics, Inc. engages in the development of therapies for the treatment and prevention of osteoporosis and related bone diseases. Its product OSTORA, is an oral formulation of calcitonin, which is a recombinant peptide hormone that inhibits bone resorption. The company was founded by David Brand and James Gilligan in 2009 and is headquartered in Philadelphia, PA. | 3 años |
| Terese Gieselman | F | 62 | 1 años | |
| Thomas D'Orazio | M | - | - | |
| Luke Hayes | M | - | - | |
| Lawrence Woo | M | - | - | |
| Joy Willis | F | - | 1 años |
Estadísticas
| País | Relaciones | % del total |
|---|---|---|
| Canadá | 16 | 72.73% |
| Estados Unidos | 6 | 27.27% |
Antigüedad de la relación
Activas
Pasados
Hombre
Mujer
Administradores
Ejecutivos
Origen de las relaciones
- Bolsa de valores
- Insiders
- James Gilligan
- Red Personal
